Modelling prognostic factors in advanced pancreatic cancer.
Pancreatic cancer is the fifth most common cause of cancer death. Identification of defined patient groups based on a prognostic index may improve the prediction of survival and selection of therapy. Many prognostic factors have been identified often based on retrospective, underpowered studies with...
Main Authors: | Stocken, D, Hassan, A, Altman, D, Billingham, L, Bramhall, SR, Johnson, P, Freemantle, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Choice of transformation for modelling non-linear continuous biomarkers
by: Stocken Deborah D, et al.
Published: (2011-12-01) -
A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.
by: Markham, C, et al.
Published: (2003) -
Acute pancreatitis: current perspectives on diagnosis and management
by: Shah AP, et al.
Published: (2018-03-01) -
Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model
by: Ching-Fu Chang, et al.
Published: (2019-01-01) -
Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer
by: Ipek Alpertunga, et al.
Published: (2021-02-01)